Introduction
Asthma is a chronic respiratory disease that affects millions of people worldwide. It causes inflammation and narrowing of the airways, leading to breathing difficulties, coughing, wheezing, and chest tightness. Although asthma can't be cured entirely, it can be managed effectively with proper treatment guidelines for asthma. As medical professionals, following these guidelines is critical to help patients achieve optimal control over their symptoms and prevent exacerbations or hospitalizations.
Causes of Asthma
One major factor in the development of asthma is genetics. People with a family history of asthma or allergies are more likely to develop the condition themselves. Additionally, exposure to environmental allergens such as pollen, dust mites, and animal dander can also contribute to the onset of asthma symptoms.
Another potential cause of asthma is respiratory infections during childhood. These infections can lead to lung damage and inflammation which may increase the risk for developing asthma later in life.
The first type of asthma is allergic or atopic asthma, which occurs due to an immune response triggered by allergens such as dust mites, pollen, and animal dander. It's the most common type of asthma in children.
Non-allergic or intrinsic asthma results from other factors like exercise, cold weather, air pollutants or infections. This type often develops during adulthood and can be challenging to diagnose since it doesn't show any signs of allergies.
Asthma is a chronic respiratory disease that affects millions of people worldwide. It's important to note that asthma can be controlled with the right treatment and by following the relevant guidelines for asthma treatment.
By understanding the different types of asthma, healthcare professionals can provide accurate diagnoses and develop appropriate treatment plans based on individual symptoms and triggers.
Guidelines for asthma treatment offer an evidence-based approach to managing this complex condition, ensuring that patients receive effective therapies while minimizing potential side effects.
1.
FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma
2.
The Early Progression of Prostate Cancer Is Not Stopped by Metformin.
3.
Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease
4.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
5.
Tipiracil hydrochloride and trifluridine tablets are approved by the USFDA for Natco Pharma.
1.
Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction
2.
Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication
3.
Understanding Iron Saturation Levels in Your Blood
4.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
5.
Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
3.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
4.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation